The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Third-Generation Sequencing Technology Market By The End Of 2030?
The market size for third-generation sequencing technology has seen rapid expansion in recent years. It is projected to increase from $14 billion in 2025 to $15.96 billion in 2026, at a compound annual growth rate (CAGR) of 14.0%. This historical growth can be attributed to several factors including increased funding for genomics research, the limitations of short-read sequencing, the adoption by academic research institutions, a rise in studies related to rare diseases, and continuous technology innovation.
The market size for third-generation sequencing technology is anticipated to grow rapidly over the next few years. It is projected to expand to $26.71 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.7%. This anticipated growth during the forecast period can be attributed to several factors including the expansion of precision medicine, the increased adoption of clinical diagnostics, a reduction in sequencing costs, the integration of AI analytics, and population genomics initiatives. Major developments expected in the forecast period include advances in long-read sequencing technologies, the capability for real-time DNA sequencing, broader clinical genomics adoption, single-molecule sequencing, and the development of portable sequencing platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28340&type=smp
What Primary Drivers Are Shaping The Development Of The Third-Generation Sequencing Technology Market?
The anticipated expansion of the third-generation sequencing technology market is attributed to the growing embrace of personalized medicine. This medical approach involves customizing treatment and prevention based on an individual’s distinct genetic composition, lifestyle, and surroundings. The rise in personalized medicine’s uptake primarily stems from genomic advancements, allowing for accurate identification of genetic variations and customized individual treatments. Third-generation sequencing technology plays a crucial role in advancing personalized medicine by providing long-read, highly accurate genomic data, which facilitates the precise detection of genetic variations. It supports bespoke treatment plans by offering in-depth understanding of individual genomes, thereby enhancing clinical results and progressing precision healthcare. An illustration of this trend is observed in February 2024, where the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 novel personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the increasing adoption of personalized medicine is propelling the growth of the third-generation sequencing technology market.
Which Segment Classifications Shape The Third-Generation Sequencing Technology Market?
The third-generation sequencing technology market covered in this report is segmented –
1) By Technology Type: Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing
2) By Workflow: Sample Preparation, Sequencing, Data Analysis, Data Interpretation, Data Storage And Management
3) By Application: Genomics, Transcriptomics, Epigenomics, Metagenomics, Personalized Medicine, Synthetic Biology
4) By End-User: Academic Institutions, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Research Organizations, Government And Non-Profit Organizations
Subsegments:
1) By Single-Molecule Real-Time Sequencing (SMRT): Zero-Mode Waveguides (ZMWs), Circular Consensus Sequencing (CCS), High-Fidelity (HiFi) Reads
2) By Nanopore Sequencing: Portable Nanopore Sequencers, Benchtop Nanopore Sequencers, High-Throughput Nanopore Platforms
How Are Trends Impacting The Third-Generation Sequencing Technology Market?
Major companies in the third-generation sequencing technology market are concentrating on developing advanced sequencing platforms, such as ultra-fast and expandable systems, to enhance research efficiency, improve clinical applicability, and reduce turnaround times and costs. These ultra-rapid and scalable sequencing systems denote innovative technologies that enable high-throughput, real-time genomic analysis with exceptional speed and accuracy, facilitating comprehensive genomic profiling across diverse applications. For instance, in February 2025, Roche Holding AG, a Switzerland-based pharmaceutical company, launched its Sequencing by Expansion (SBX) technology. This fully integrated, next-generation sequencing system utilizes a patented biochemical process to encode DNA or RNA sequences into measurable surrogate polymers called Xpandomers, enabling highly accurate single-molecule nanopore sequencing. The SBX platform incorporates ultra-rapid, scalable sequencing capabilities and automated data analysis, delivering whole-genome sequencing results in hours rather than days without extensive manual intervention.
Which Companies Are Expanding Their Footprint In The Third-Generation Sequencing Technology Market?
Major companies operating in the third-generation sequencing technology market are Oxford Nanopore Technologies, Pacific Biosciences, Quantapore, Ultima Genomics, BGI Genomics, MGI Tech, Complete Genomics, Stratos Genomics, VisiGen Biotechnologies, Helicos Biosciences, Genia Technologies, Electronic Bio Sciences, Quantum Biosystems, Base4 Innovation, Nabsys, Chronix Biomedical, Roche, Nanopore Diagnostics, GenapSys, SomaLogic
Read the full third-generation sequencing technology market report here:
How Does The Third-Generation Sequencing Technology Market Perform Across Major Global Regions?
North America was the largest region in the third-generation sequencing technology market in 2025. The regions covered in the third-generation sequencing technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Third-Generation Sequencing Technology Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28340&type=smp
Browse Through More Reports Similar to the Global Third-Generation Sequencing Technology Market 2026, By The Business Research Company
Clinical Oncology Next Generation Sequencing Market Report 2026
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model